Articles

ARGX stock results show that argenx missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More

TNK stock results show that Teekay Tankers beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More

Takeda Pharmaceutical just reported results for the fourth quarter of 2023. More

ICL stock results show that ICL Group met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More

Explore key insights on analyst downgrades as markets react to economic shifts, corporate challenges, and stock valuations. More

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. More

After dropping to just above $59,000, Bitcoin is back above $63,000, creating opportunity for some of the best crypto mining stocks to buy. More

Subscriber Sign in